VivoSeq
Other

Concentration

0

Pipeline Programs

26

Active Trials

41

Companies Involved

Concentration is an early-stage landscape with 0 programs across 41 companies. The most active players are Pfizer, Astellas, AstraZeneca.

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

36/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

9/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

331

clinical trials

Completed241 · 73%
Unknown status32 · 10%
Terminated20 · 6%
Recruiting15 · 5%
Withdrawn11 · 3%
Active, not recruiting5 · 2%
Other7 · 2%

Trial Activity

331 trials

Ropivacaine Concentration and Rebound Pain
Recruiting·OOslo University Hospital·Phase 4·NCT06950372·80 enrolled
Urinary Concentration After Salmeterol
Recruiting·UUniversity of Copenhagen·N/A·NCT06657547·24 enrolled
Chest CT Using Low-concentration Iodine Contrast Media
Recruiting··Phase 4·NCT05967117·370 enrolled
Page 1 of 23

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)